Gastroenterology Research and Practice / 2012 / Article / Tab 2

Research Article

Hyperthermic Intraperitoneal Chemotherapy with Melphalan: A Summary of Clinical and Pharmacological Data in 34 Patients

Table 2

Univariate analysis of clinical factors associated with grade 4 postoperative morbidity in 34 patients treated with cytoreductive surgery and HIPEC with melphalan.

Clinical variable Grade 4 morbidity value

Dose of melphalan0.01
 50 mg/m20
 60 mg/m20
 70 mg/m24
Number of peritonectomies<0.001
Number of visceral resections0.002
Peritoneal cancer index0.38

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.